APA (7th ed.) Citation

EG, S., A, M., CC, J., D, L., X, F., D, S., . . . AJ, M. (2022). Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings. The oncologist, 27(3), 175. https://doi.org/10.1093/oncolo/oyab064

Chicago Style (17th ed.) Citation

EG, Sturgill, et al. "Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings." The Oncologist 27, no. 3 (2022): 175. https://doi.org/10.1093/oncolo/oyab064.

MLA (9th ed.) Citation

EG, Sturgill, et al. "Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings." The Oncologist, vol. 27, no. 3, 2022, p. 175, https://doi.org/10.1093/oncolo/oyab064.